Current label answer
Wegovy does not carry tirzepatide’s 4-week backup-method instruction
The manufacturer Wegovy label effective June 18, 2026 includes both subcutaneous injection and once-daily tablets. It says semaglutide delays gastric emptying and may affect absorption of oral medicines, but it does not include the Zepbound and Mounjaro instruction to use a non-oral contraceptive method or add a barrier method for 4 weeks after starting and after each dose escalation. Those tirzepatide instructions should not be transferred automatically to Wegovy.
- Do not describe all GLP-1 medicines as having the same contraception warning; active ingredient, route, product label, and clinical situation matter.
- The Wegovy clinical pharmacology section reports no clinically significant pharmacokinetic differences for ethinyl estradiol or levonorgestrel with semaglutide, but those ingredients do not represent every pill or every contraceptive method.
- Do not interpret the absence of a tirzepatide-style backup window as permission to ignore vomiting, diarrhea, missed pills, interacting medicines, pregnancy plans, or method-specific instructions.
Injection and tablet identity
Weekly injection and once-daily tablets create different practical questions
Current labeled Wegovy is not injection-only. The injection is administered subcutaneously once weekly, while Wegovy tablets are taken once daily on an empty stomach in the morning with up to 4 ounces of water. The tablet label says to wait at least 30 minutes before food, beverages, or other oral medicines. This administration routine is separate from contraceptive effectiveness and should not be turned into an improvised spacing rule for a birth-control pill.
- For Wegovy injection, ask whether gastrointestinal symptoms, other medicines, or a missed contraceptive pill change the contraception plan; do not invent a universal pill-spacing interval.
- For Wegovy tablets, ask the prescriber or pharmacist how to fit the labeled empty-stomach routine around the exact oral contraceptive and other morning medicines.
- Do not split, crush, move, skip, double, or change either medicine to solve a timing conflict without product-specific professional instructions.
Vomiting, diarrhea, and missed pills
Gastrointestinal symptoms can create a separate contraception question
Nausea, vomiting, and diarrhea are recognized Wegovy adverse effects. Vomiting or significant diarrhea can also raise method-specific questions for people relying on an oral contraceptive, depending on timing, duration, the pill’s instructions, and whether doses were missed. The Wegovy label does not replace the contraceptive product’s missed-pill or illness guidance.
- Record the Wegovy route and dose date, contraceptive name and pill time, symptom onset and duration, missed doses, and whether pregnancy prevention may have been interrupted.
- Contact the contraception clinician, pharmacist, or prescriber promptly for method-specific instructions rather than using a social-media backup schedule.
- Seek urgent medical care for severe or persistent vomiting, inability to keep fluids down, fainting, confusion, markedly reduced urination, severe abdominal pain, or another emergency pattern.
Pregnancy planning
Contraception review matters because Wegovy has pregnancy-specific guidance
For weight reduction or cardiovascular risk reduction, the current Wegovy label says to discontinue treatment when pregnancy is recognized. It also says to discontinue Wegovy at least 2 months before a planned pregnancy because semaglutide has a long half-life. The label separately addresses MASH, so patients should not flatten every indication into one sentence or self-direct a stop-and-restart plan.
- Discuss possible pregnancy, pregnancy plans, fertility treatment, breastfeeding, postpartum status, irregular cycles, PCOS, and contraception changes before starting or refilling Wegovy.
- Contact the prescriber promptly if pregnancy occurs or may have occurred; do not take another dose, restart later, or use leftover medicine based on an online timeline.
- Coordinate with an OB-GYN or fertility clinician when pregnancy timing, emergency contraception, a missed period, or conflicting medication advice needs individualized review.
Product boundaries
Wegovy, Ozempic, tirzepatide, and compounded products are not interchangeable
Wegovy is FDA-approved branded semaglutide under its own current injection-and-tablet label. Ozempic and Rybelsus are separate semaglutide product identities with their own indications and routines. Zepbound and Mounjaro contain tirzepatide and have the specific oral hormonal contraception warning discussed above. A patient-specific compounded semaglutide preparation is not FDA-approved Wegovy, does not inherit the branded label as its own approval, and may have a different route, concentration, inactive ingredients, pharmacy directions, and follow-up plan.
- Verify the carton or bottle, route, active ingredient, prescriber, pharmacy, patient label, and current medication list before applying interaction advice.
- If compounded semaglutide is discussed, ask why it is clinically and legally appropriate, which licensed pharmacy dispenses it, and how formulation-specific questions are reviewed.
- Reject no-prescription GLP-1 sellers, research-use products sold for treatment, hidden pharmacy sourcing, copied tirzepatide instructions, and claims that compounded semaglutide is FDA-approved Wegovy.
Care coordination
Ask for one written plan that names both products
A useful answer should identify the exact Wegovy formulation and contraceptive method rather than saying only that “GLP-1s affect the pill” or “there is no interaction.” Ask the responsible clinicians or pharmacist to document the tablet routine if relevant, what to do after vomiting or diarrhea, which contraceptive instructions apply after a missed pill, how pregnancy concerns are handled, and who should be contacted after hours.
- Bring the actual contraception package name and Wegovy presentation to the visit or portal message; ingredient and route details matter.
- Ask whether another prescription, supplement, gastrointestinal condition, or recent medication change affects either treatment.
- Do not use emergency contraception, add or remove a barrier method, stop birth control, or change Wegovy solely from a seller page, forum, or generalized GLP-1 chart.